Field Service Engineer - Scotland UK&I

Scotland, United Kingdom

Apply with AI Apply

Not SpecifiedCompensation

Junior (1 to 2 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Genomics, Life SciencesIndustries

Requirements

Candidates should hold a qualification in Electrical / Electronic Engineering, Mechanical Engineering, Biosciences or a similar field, and possess previous field-based experience, preferably in the biotechnology/biomedical industry or military experience. They should also have demonstrable strong problem-solving skills, excellent customer-facing abilities, and good technical abilities. Fluent English language skills and a valid UK driving license are essential.

Responsibilities

The Field Service Engineer will be responsible for providing on-site service of Illumina equipment at customer sites, including installations, troubleshooting, servicing, and repairs of complex equipment and systems. They will interface with internal support structures, provide technical assistance to customers, staff, and contractors, install and maintain instrument systems within their territory, and manage service parts inventory levels. Additionally, they will complete administrative work, maintain customer information and technical files, and work in conjunction with other staff to coordinate new system placements and promote upgrades. Travel up to 80% across Scotland, and occasionally Northern England and UK & Ireland, is required.

Skills

Equipment installation

Troubleshooting

Servicing

Repairs

Customer support

Technical assistance

Genetics

Next Generation Sequencing (NGS)

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

San Diego, CaliforniaHeadquarters

1998Year Founded

$27.2MTotal Funding

IPOCompany Stage

Venture Capital, BiotechnologyIndustries

5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.

Standardizing proteomics data across platforms could challenge Illumina's data reliability.

Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.

The company offers innovative array-based solutions for DNA, RNA, and protein analysis.

Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.

Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.

Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI

Try Jobo Free